Immediate Impact
1 from Science/Nature 73 standout
Citing Papers
Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
2024 Standout
Hallmarks of cancer stemness
2024 Standout
Works of N. C. Tebbutt being referenced
YOSEMITE: A 3 arm double-blind randomized phase 2 study of gemcitabine, paclitaxel protein-bound particles for injectable suspension, and placebo (GAP) versus gemcitabine, paclitaxel protein-bound particles for injectable suspension and either 1 or 2 truncated courses of demcizumab (GAD)
2017
A phase I trial of imatinib in combination with mFOLFOX6–bevacizumab in patients with advanced colorectal cancer
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| N. C. Tebbutt | 123 | 68 | 42 | 17 | 170 | |
| Jietian Jin | 153 | 126 | 25 | 16 | 273 | |
| Satoshi Shinya | 83 | 78 | 89 | 17 | 232 | |
| Irene Pecora | 125 | 92 | 16 | 22 | 196 | |
| Yan Liu | 58 | 121 | 23 | 19 | 183 | |
| Carlijn van de Water | 67 | 42 | 21 | 11 | 141 | |
| Giorgio Bonciarelli | 161 | 57 | 50 | 21 | 263 | |
| Luisa Piccin | 160 | 63 | 30 | 16 | 207 | |
| Rocco Giannicola | 96 | 58 | 8 | 16 | 189 | |
| Wafaa Elatre | 84 | 111 | 23 | 12 | 200 | |
| Aydın Çiltaş | 39 | 40 | 19 | 16 | 137 |
All Works
Loading papers...